Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease-Reference-Cited by-同舟云学术

Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease

Published:1991-02 Issue:2 Volume:77 Page:185-190
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

San Miguel J. F.,Gonzáalez M.,Gascón A.,Moro Ma J.,Hernáandez J. M.,Ortega F.,Jimenez R.,Guerras L.,Romero M.,Casanova F.,Sanz M. A.,Sáanchez J.,Portero J. A.,Orfao A.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1991.tb07975.x/fullpdf

Reference22 articles.

1. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.

2. CALLA-positive myeloma: an aggressive subtype with poor survival

3. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

4. Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14);Frontiers in Oncology;2022-12-01

2. Targeted Therapy With Immunoconjugates for Multiple Myeloma;Frontiers in Immunology;2020-06-19

3. CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation;British Journal of Haematology;2018-09-10

4. Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry;Clinics in Laboratory Medicine;2017-12

5. Immunotherapies targeting CD38 in Multiple Myeloma;OncoImmunology;2016-08-05